t2dm, meets provider criteria for insulin initiation; starting or having started insulin treatment no longer than six months prior to enrollment or has not yet committed to starting insulin but has agreed to participate in the education

broadband internet and experience with logging into a password-protected site (e.g., ecommerce or social networking);

ability to purchase or otherwise acquire glargine/detemir insulin and testing supplies.

use of oral glucocorticoids or second generation anti-psychotics;

previous use of self-administered insulin more than six months prior to enrollment;

gestational diabetes or other endocrine conditions causing hyperglycemia; treatment for a malignant condition other than basal cell carcinoma in situ within prior two years;

renal insufficiency (ast/alt >2 or concurrent liver disease except nash);

pregnant or planning to become pregnant within 6 months;

hba1c < 7.0% or ongoing weight loss or persistent fasting hyperglycemia > 250 mg/dl.